Company Profile
Pediatrix Medical Group, Inc. Stock Price, News & Analysis
- Ticker:
- MD
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
25.58 USD (-0.97%)
Close
Last updated: July 23, 2026
1.79B USD
Market cap
Why the stock is moving
MD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Pediatrix Medical Group is a physician-led healthcare services company focused on newborn, maternal-fetal, and pediatric care. Its business is centered on clinical service delivery rather than biotech or devices.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Pediatrix sits in healthcare services.
Business Model Characteristics
Revenue depends on physician staffing, service volume, reimbursement, and the economics of hospital-based care.
Position Within the Biotechnology Landscape
Pediatrix is outside biotech and belongs to the healthcare-services layer where execution and reimbursement dominate.
Future catalysts
Pediatrix Medical Group's catalysts are newborn-care volumes, reimbursement, and labor execution in a physician-services business that moves more on operations than on pipeline headlines. The next update matters if it shows the care-delivery base is stable enough to support margin recovery and a cleaner growth profile.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast
BRKR · Source: Bruker
- 02
Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
DGX · Source: Quest Diagnostics
- 03
Molina Healthcare Reports Second Quarter 2026 Financial Results
MOH · Source: Molina Healthcare
- 04
Axon to Release Second Quarter 2026 Earnings on August 5, 2026
AXON · Source: Axon Enterprise, Inc.
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Pediatrix Medical Group, Inc. (MD)?
Pediatrix Medical Group, Inc. (MD) most recently closed at 25.58 USD, a -0.97% move versus the previous session.
What is the market cap of Pediatrix Medical Group, Inc. (MD)?
Pediatrix Medical Group, Inc. currently has a market capitalization of 1.79B USD on BioPharmSignal.
What does Pediatrix Medical Group, Inc. do?
Pediatrix Medical Group is a physician-led healthcare services company focused on newborn, maternal-fetal, and pediatric care. Its business is centered on clinical service delivery rather than biotech or devices.
On which exchange is MD stock listed?
Pediatrix Medical Group, Inc. (MD) is associated with NYSE, United States, Biopharma.
What is Pediatrix?
Pediatrix Medical Group's catalysts are newborn-care volumes, reimbursement, and labor execution in a physician-services business that moves more on operations than on pipeline headlines.
Which conditions is Pediatrix Medical Group, Inc. targeting with Pediatrix?
Pediatrix Medical Group's catalysts are newborn-care volumes, reimbursement, and labor execution in a physician-services business that moves more on operations than on pipeline headlines.
How does Pediatrix Medical Group, Inc. describe recent progress with Pediatrix?
Pediatrix Medical Group's catalysts are newborn-care volumes, reimbursement, and labor execution in a physician-services business that moves more on operations than on pipeline headlines.
What is Medical?
Pediatrix Medical Group is a physician-led healthcare services company focused on newborn, maternal-fetal, and pediatric care.